1、UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended September 30,2024OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE A

2、CT OF 1934For the transi?on period from to Commission File Number:001-35565AbbVie Inc.(Exact name of registrant as specified in its charter)Delaware32-0375147(State or other jurisdic?on of incorpora?on or organiza?on)(I.R.S.employer iden?fica?on number)1 North Waukegan RoadNorth Chicago,Illinois 600

3、64-6400Telephone:(847)932-7900Indicate by check mark whether the registrant(1)has filed all reports required to be filed by Sec?on 13 or 15(d)of the Securi?es Exchange Act of 1934 during the preceding 12months(or for such shorter period that the registrant was required to file such reports),and(2)ha

4、s been subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submi?ed electronically every Interac?ve Data File required to be submi?ed pursuant to Rule 405 of Regula?on S-T(232.405 ofthis chapter)during the preceding 12 months(or for such

5、shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller repor?ng company,or an emerging growthcompany.See the defini?ons of“large accelerated filer,”

6、“accelerated filer,”“smaller repor?ng company,”and emerging growth company in Rule 12b-2 of the Exchange Act.Large Accelerated FilerAccelerated FilerNon-Accelerated FilerSmaller repor?ng companyEmerging growth companyIf an emerging growth company,indicate by check mark if the registrant has elected